| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | tubastatin A | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.22 | 0.0002 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.21 | 0.0003 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0004 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.14 | 0.0007 |